Literature DB >> 2140112

Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.

G Aubert, S Passot, F Lucht, G Dorche.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2140112     DOI： 10.1093/jac/25.3.491

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  15 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

2.  Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.

Authors:  K Sieradzki; P Villari; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

3.  Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.

Authors:  W M Milewski; S Boyle-Vavra; B Moreira; C C Ebert; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1997-04       Impact factor: 3.490

Review 5.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 6.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Emergence of teicoplanin-resistant coagulase-negative staphylococci.

Authors:  E Cercenado; M E García-Leoni; M D Díaz; C Sánchez-Carrillo; P Catalán; J C De Quirós; E Bouza
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

8.  Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.

Authors:  B E Domaracki; A Evans; K E Preston; H Fraimow; R A Venezia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

9.  Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.

Authors:  A Kureishi; P J Jewesson; M Rubinger; C D Cole; D E Reece; G L Phillips; J A Smith; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic.

Authors:  B P Goldstein; G Candiani; T M Arain; G Romanò; I Ciciliato; M Berti; M Abbondi; R Scotti; M Mainini; F Ripamonti
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.